DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69 million versus the consensus estimate of $60.2 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.